# Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

> **NCT07334574** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 20 (estimated)

## Conditions studied

- B-cell Non-Hodgkin's Lymphoma (B-NHL)

## Interventions

- **BIOLOGICAL:** Personalized neoantigen tumor vaccine

## Key facts

- **NCT ID:** NCT07334574
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07334574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07334574, "Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07334574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*